GVBL stock news
This page provides real-time market news, earnings updates, and company announcements related to Genomic Valley Biotech Ltd (GVBL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-25 05:59 IST
Tempus AI’s 5.98% Stock Drop Drives $300M Surge in Volume Ranking 451st Amid Year-Long 15.8% Gains
101 finance2026-03-13 00:51:44
Aprea Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides a Corporate Update
Finviz2026-03-16 12:03:48
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom
101 finance2026-03-16 14:48:51
Natera's Zenith Genomics Launch Sparks 5.23% Stock Surge, Outperforming Market Amid 379th Trading Volume Rank
101 finance2026-03-17 00:43:01
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors
Finviz2026-03-17 21:57:46
Cibus (CBUS) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-17 23:18:44
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
Finviz2026-03-18 12:06:10
Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative
Finviz2026-03-18 13:09:57
Big Pharma Learns a $3.4 Billion Lesson: Bringing Abandoned Medicines Back to Market May Benefit Millions of People
101 finance2026-03-19 11:57:43
ILMN Shares Rise After Broadened Partnership With Labcorp
101 finance2026-03-19 18:27:48
MyOme’s all-in-one CAD iPRS may revolutionize preventive healthcare—But is the industry prepared for this change?
101 finance2026-03-20 11:42:44
Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients
Finviz2026-03-20 12:33:48
Caris Life Sciences’ GPSai Drives the S-Curve of AI Infrastructure in Precision Oncology—Market Overlooks the Momentum
101 finance2026-03-20 13:03:53
Agilent's 0.40% Stock Decline Contrasts 59.18% Volume Surge Ranking 454th as AI Automation and Strategic Partnerships Fuel Investor Interest
101 finance2026-03-21 01:01:13
ARK's TXG Trim Triggers Excessive Market Response—Gene-Editing Investments Suggest a Shift in Genomics Strategy
101 finance2026-03-21 21:36:57
Cathie Wood’s CRISPR Investment: Seizing the Downturn During Biotech Volatility and Positioning for a Speculation-Fueled Comeback
101 finance2026-03-22 00:39:40
GeneDx: Market Overlooks Robust Performance, Dismisses Growing Data Advantage and $156 Estimated True Value
101 finance2026-03-22 06:24:48
GeneDx: 71% Gross Margin Powerhouse Trading at a 33% Discount to DCF-Based Fair Value
101 finance2026-03-22 06:33:56
Here Are the Sole 3 Stocks Cathie Wood Purchased in the Past Week
101 finance2026-03-23 11:36:17
Tempus AI’s diagnostic and data divisions Propel Sustainable Growth Over Time
101 finance2026-03-23 17:21:42
ReMerGify’s Edge MicroDatacenter Targets Biotech AI’s Critical Bottleneck—Latency and Security—With First-Mover Infrastructure Play
101 finance2026-03-23 17:57:45
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
Finviz2026-03-23 20:09:49
Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month
Finviz2026-03-24 12:33:50
Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data
Finviz2026-03-24 13:18:48
Acrivon Therapeutics to Present Pre-Clinical AP3 Data at the 2026 AACR Annual Meeting Revealing Strong Synergy of ACR-368 with ADC Topo 1 Inhibitor Payloads and of both ACR-368 and ACR-2316 with Immune Checkpoint Inhibitors
Finviz2026-03-17 21:57:46
Cibus (CBUS) Fourth Quarter 2025 Earnings Conference Call Transcript
101 finance2026-03-17 23:18:44
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
Finviz2026-03-18 12:06:10
Basecamp Research Selects PacBio HiFi Sequencing to Power Trillion Gene Atlas Initiative
Finviz2026-03-18 13:09:57
Big Pharma Learns a $3.4 Billion Lesson: Bringing Abandoned Medicines Back to Market May Benefit Millions of People
101 finance2026-03-19 11:57:43
ILMN Shares Rise After Broadened Partnership With Labcorp
101 finance2026-03-19 18:27:48
MyOme’s all-in-one CAD iPRS may revolutionize preventive healthcare—But is the industry prepared for this change?
101 finance2026-03-20 11:42:44
Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients
Finviz2026-03-20 12:33:48
Caris Life Sciences’ GPSai Drives the S-Curve of AI Infrastructure in Precision Oncology—Market Overlooks the Momentum
101 finance2026-03-20 13:03:53
Agilent's 0.40% Stock Decline Contrasts 59.18% Volume Surge Ranking 454th as AI Automation and Strategic Partnerships Fuel Investor Interest
101 finance2026-03-21 01:01:13
ARK's TXG Trim Triggers Excessive Market Response—Gene-Editing Investments Suggest a Shift in Genomics Strategy
101 finance2026-03-21 21:36:57
Cathie Wood’s CRISPR Investment: Seizing the Downturn During Biotech Volatility and Positioning for a Speculation-Fueled Comeback
101 finance2026-03-22 00:39:40
GeneDx: Market Overlooks Robust Performance, Dismisses Growing Data Advantage and $156 Estimated True Value
101 finance2026-03-22 06:24:48
GeneDx: 71% Gross Margin Powerhouse Trading at a 33% Discount to DCF-Based Fair Value
101 finance2026-03-22 06:33:56
Here Are the Sole 3 Stocks Cathie Wood Purchased in the Past Week
101 finance2026-03-23 11:36:17
Tempus AI’s diagnostic and data divisions Propel Sustainable Growth Over Time
101 finance2026-03-23 17:21:42
ReMerGify’s Edge MicroDatacenter Targets Biotech AI’s Critical Bottleneck—Latency and Security—With First-Mover Infrastructure Play
101 finance2026-03-23 17:57:45
Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026
Finviz2026-03-23 20:09:49
Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month
Finviz2026-03-24 12:33:50
Verana Health and Guardant Health Partner to Advance Precision Medicine with Real-World Data
Finviz2026-03-24 13:18:48
GVBL stock price change
On the last trading day, GVBL stock closed at 28.56 INR, with a price change of 0.46% for the day.
Trade stock perpsGVBL stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more